Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Cost of Revenue (2022)

Historic Cost of Revenue for Pasithea Therapeutics (KTTA) over the last 1 years, with Q4 2022 value amounting to -$1308.0.

  • Pasithea Therapeutics' Cost of Revenue changed N/A to -$1308.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $113195.0, marking a year-over-year change of. This contributed to the annual value of $113195.0 for FY2022, which is 55525.33% up from last year.
  • Per Pasithea Therapeutics' latest filing, its Cost of Revenue stood at -$1308.0 for Q4 2022.
  • Over the past 5 years, Pasithea Therapeutics' Cost of Revenue peaked at $86465.0 during Q3 2022, and registered a low of -$1308.0 during Q4 2022.